CG Oncology (CGON) Current Leases (2023 - 2026)
CG Oncology (CGON) posted Current Leases of $1.1 million for Q1 2026, up 16.5% on a QoQ basis from $915000.0 in Q4 2025, and up 318.04% year-over-year from $255000.0 in Q1 2025.
CG Oncology (CGON) Current Leases (2023 - 2026) Analysis & Trends
CG Oncology's Current Leases history runs 4 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Current Leases rose 318.04% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 318.04% YoY) and the FY2025 annual result came in at $915000.0, up 391.94% from the prior year.
- Current Leases was $1.1 million for Q1 2026 at CG Oncology, up from $915000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.1 million in Q1 2026 and bottomed at $186000.0 in Q4 2024.
- A 4-year average of $452100.0 and a median of $246000.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases dropped 14.29% — and 2025, when it soared 391.94%.
- CG Oncology's Current Leases stood at $217000.0 in 2023, then dropped by 14.29% to $186000.0 in 2024, then surged by 391.94% to $915000.0 in 2025, then advanced by 16.5% to $1.1 million in 2026.
- Business Quant data shows CGON's Current Leases at $1.1 million in Q1 2026, $915000.0 in Q4 2025, and $912000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 915,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2025 | 288,000.00 |
| Mar 31, 2025 | 255,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Sep 30, 2024 | 225,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 217,000.00 |